ProfileGDS4718 / 1561544_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 12% 8% 11% 8% 8% 16% 14% 8% 15% 8% 9% 9% 12% 8% 15% 8% 6% 25% 15% 10% 11% 8% 9% 8% 10% 12% 15% 12% 9% 13% 18% 12% 13% 13% 15% 16% 13% 9% 13% 8% 12% 17% 14% 17% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8820912
GSM549102patient 115, normal, homogenized [OPG study]3.701348
GSM549104patient 119, normal, homogenized [OPG study]3.7813711
GSM549108patient 138, normal, homogenized [OPG study]3.722578
GSM549119patient 077, normal, homogenized [OPG study]3.694538
GSM549133patient 032, cancer, homogenized [OPG study]3.9574916
GSM549139patient 042, cancer, homogenized [OPG study]3.9209414
GSM549099patient 107, normal, homogenized [OPG study]3.719958
GSM549109patient 139, normal, homogenized [OPG study]3.9899815
GSM549110patient 046, normal, homogenized [OPG study]3.717528
GSM549114patient 063, normal, homogenized [OPG study]3.711799
GSM549122patient 082, normal, homogenized [OPG study]3.758839
GSM549134patient 033, cancer, homogenized [OPG study]3.8691612
GSM549136patient 036, cancer, homogenized [OPG study]3.679998
GSM549140patient 044, cancer, homogenized [OPG study]3.9385315
GSM549111patient 047, normal, homogenized [OPG study]3.703188
GSM549113patient 057, normal, homogenized [OPG study]3.616536
GSM549132patient 031, cancer, homogenized [OPG study]4.3243725
GSM549137patient 038, cancer, homogenized [OPG study]3.9503815
GSM549142patient 047, cancer, homogenized [OPG study]3.8241710
GSM549100patient 110, normal, homogenized [OPG study]3.8157211
GSM549107patient 135, normal, homogenized [OPG study]3.672968
GSM549115patient 068, normal, homogenized [OPG study]3.713089
GSM549116patient 072, normal, homogenized [OPG study]3.692378
GSM549120patient 078, normal, homogenized [OPG study]3.7801810
GSM549131patient 030, cancer, homogenized [OPG study]3.8136312
GSM549118patient 074, normal, homogenized [OPG study]3.9762615
GSM549129patient 027, cancer, homogenized [OPG study]3.8670712
GSM549123patient 088, normal, homogenized [OPG study]3.754029
GSM549124patient 006, cancer, homogenized [OPG study]3.9149413
GSM549126patient 015, cancer, homogenized [OPG study]4.048318
GSM549128patient 025, cancer, homogenized [OPG study]3.8260512
GSM549103patient 117, normal, homogenized [OPG study]3.9114113
GSM549117patient 073, normal, homogenized [OPG study]3.9025913
GSM549138patient 041, cancer, homogenized [OPG study]3.9287415
GSM549141patient 045, cancer, homogenized [OPG study]3.9597416
GSM549130patient 028, cancer, homogenized [OPG study]3.9114213
GSM549101patient 111, normal, homogenized [OPG study]3.730259
GSM549105patient 128, normal, homogenized [OPG study]3.9037813
GSM549106patient 134, normal, homogenized [OPG study]3.657378
GSM549112patient 048, normal, homogenized [OPG study]3.8648612
GSM549125patient 011, cancer, homogenized [OPG study]4.0313517
GSM549127patient 024, cancer, homogenized [OPG study]3.9066414
GSM549135patient 035, cancer, homogenized [OPG study]3.9733117